GovChime
Notice ID: 39b8226bbde34b448043b515857536d0Special Notice

Q301--NEW – STX Specialized Molecular Residual Disease Testing

Active, responses due . Full description on SAM.gov.

Overview

Response deadline
10:00 AM CDT
Posted
October 22, 2026
Notice type
Special Notice
NAICS
621511: Medical Laboratories
Agency
Department of Veterans Affairs

Notice details

Office
257-NETWORK CONTRACT OFFICE 17 (36C257)
PSC
Q301: REFERENCE LABORATORY TESTING
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
36C25727Q0058
Notice ID
39b8226bbde34b448043b515857536d0

Description

Special Notice Special Notice Page 3 of 3 Special Notice *= Required Field Special Notice Page 1 of 3 1. NOTICE OF INTENT DESCRIPTION The Department of Veterans Affairs, Network Contracting Office (NCO) 17, located at 5441 Babcock Road, Suite 302, San Antonio, TX 78229, intends to award an Indefinite Delivery Indefinite Quantity (IDIQ) Firm Fixed Price contract with five ordering periods on a sole-source basis to: Natera, Inc. 13011 McCallen Pass Austin, TX 78752 This requirement is for proprietary molecular genetic reference testing services used in the evaluation and monitoring of transplant patients and cancer residual disease. 2. SUPPLIES/SERVICES Item 0001 Description: Signatera Only, CPT Codes 81479, 81455 Estimated Quantity: 35 Unit: Each Item 0002 Description: Prospera, CPT Code 81479 Estimated Quantity: 25 Unit: Each Natera is the sole provider of these proprietary medical laboratory tests, including: Prospera molecular expression transplant assessment test Signatera Residual Disease Test (MRD) (non liquid biopsy tumor typing) No other vendor possesses the proprietary methodologies, assays, or intellectual property required to perform these tests. 3. SOLE SOURCE JUSTIFICATION Testing required by the VA is proprietary to Natera, Inc. No authorized distributors, third party laboratories, or alternative clinical sources exist for the Prospera and Signatera MRD tests. These assays cannot be substituted or performed by any other laboratory. Only Natera maintains the necessary technology, reagents, and bioinformatics platforms. 4. THIS NOTICE IS NOT A REQUEST FOR QUOTES This Special Notice is issued solely for information and planning purposes. It does not constitute a solicitation or a request for competitive quotes. Interested parties may submit a capability statement demonstrating an ability to perform the required testing. Responses must clearly show that an equivalent proprietary test exists and can be provided. 5. RESPONSE INSTRUCTIONS Responses must be emailed to: Susan Flores Contract Specialist, NCO 17 Email: Susan.Flores2@va.gov Deadline: November 2, 2026 at 10:00 AM CST The Government will review all responses but retains discretion regarding whether to compete this requirement. The Government is not responsible for any costs incurred in responding to this notice. 6. PLACE OF PERFORMANCE VA Facilities within VISN 17 (Texas) Specific ordering locations will be identified in individual task/delivery orders. 7. PERIOD OF PERFORMANCE Five ordering periods (exact dates to be determined at award).

Full description on SAM.gov

Award Overview

Contacts

Contracting Officer

Primary Contact

Susan Flores
Contract Specialist

Documents

Files (1)

  • 36C25727Q0058.docx

    18 KBAdded in Special Notice version 1Posted
    Download

Lifecycle

  1. 1
    Version 1Special NoticeCurrent

    Q301--NEW – STX Specialized Molecular Residual Disease Testing

    Notice 39b8226bbde34b448043b515857536d0 on SAM.gov

Similar Opportunities

Additional Details

Solicitation Number

36C25727Q0058

Archive Date

Dec 29, 2026

Office Address

San Antonio, TX, 78240